Alert: Rating Upgrade (11/8/24)-Supernus Pharmaceuticals Inc (NASDAQ: SUPN).
Stock Rating Upgrade During the last several trading days the Value Trend Rating for Supernus Pharmaceuticals Inc (NASDAQ: SUPN) improved from D to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action Supernus […]